BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27165245)

  • 1. Targeting of BUB1b Gene Expression in Sentinel Lymph Node Biopsies of Invasive Breast Cancer in Iranian Female Patients.
    Mansouri N; Movafagh A; Sayad A; Heidary Pour A; Taheri M; Soleimani S; Mirzaei HR; Alizadeh Shargh S; Azargashb E; Bazmi H; Allah Moradi H; Zandnia F; Hashemi M; Massoudi N; Mortazavi-Tabatabaei SA
    Asian Pac J Cancer Prev; 2016; 17(S3):317-21. PubMed ID: 27165245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Superior Markers for Polymerase Chain Reaction Diagnosis of Breast Cancer Micrometastasis in Sentinel Lymph Nodes.
    Alizadeh Shargh S; Movafagh A; Zarghami N; Sayad A; Mansouri N; Taheri M; Heidary Pour A; Iranpour M; Ghaedi H; Montazeri V; Massoudi N; Hashemi M; Mortazavi-Tabatabaei SA
    Asian Pac J Cancer Prev; 2016; 17(S3):179-83. PubMed ID: 27165222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients.
    Tevis SE; Bassett R; Bedrosian I; Barcenas CH; Black DM; Caudle AS; DeSnyder SM; Fitzsullivan E; Hunt KK; Kuerer HM; Lucci A; Meric-Bernstam F; Mittendorf EA; Park K; Teshome M; Thompson AM; Hwang RF
    Ann Surg Oncol; 2019 Mar; 26(3):815-820. PubMed ID: 30556120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the MUC1 Gene in Iranian Women with Breast Cancer Micrometastasis.
    Mansouri N; Movafagh A; Soleimani S; Taheri M; Hashemi M; Heidary Pour A; Alizadeh Shargh S; Mosavi-Jarahi A; Sasaninejad Z; Zham H; Hajian P; Allah Moradi H; Mirzaei HR; Fardmanesh H; Ohadi M
    Asian Pac J Cancer Prev; 2016; 17(S3):275-8. PubMed ID: 27165238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer.
    Dong LF; Xu SY; Long JP; Wan F; Chen YD
    J Int Med Res; 2018 Feb; 46(2):828-835. PubMed ID: 29441833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel Node Biopsy Examination for Breast Cancer in a Routine Laboratory Practice: Results of a Pilot Study.
    Khoo JJ; Ng CS; Sabaratnam S; Arulanantham S
    Asian Pac J Cancer Prev; 2016; 17(3):1149-55. PubMed ID: 27039740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
    Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
    World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.
    Martín-Sánchez E; Pernaut-Leza E; Mendaza S; Cordoba A; Vicente-Garcia F; Monreal-Santesteban I; Vizcaino JP; De Cerio MJ; Perez-Janices N; Blanco-Luquin I; Escors D; Ulazia-Garmendia A; Guerrero-Setas D
    Virchows Arch; 2016 Jul; 469(1):51-9. PubMed ID: 27097811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer.
    Shigematsu H; Ozaki S; Yasui D; Zaitsu J; Taniyama D; Saitou A; Kuraoka K; Yamashiro H; Taniyama K
    Breast Cancer; 2018 Mar; 25(2):191-197. PubMed ID: 29094254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
    Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
    Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancer.
    Wang HY; Sun JM; Lu HF; Shi DR; Ou ZL; Ren YL; Fu SQ
    Int J Gynecol Cancer; 2006; 16(2):643-8. PubMed ID: 16681740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of frozen section analysis of sentinel lymph nodes for the detection of Asian breast cancer micrometastasis - experience from Pakistan.
    Hashmi AA; Faridi N; Khurshid A; Naqvi H; Malik B; Malik FR; Fida Z; Mujtuba S
    Asian Pac J Cancer Prev; 2013; 14(4):2657-62. PubMed ID: 23725191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-Step Nucleic Acid Amplification Assay for Detection of Axillary Lymph Node Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Takamoto K; Shimazu K; Naoi Y; Shimomura A; Shimoda M; Kagara N; Kim SJ; Tamaki Y; Noguchi S
    Ann Surg Oncol; 2016 Jan; 23(1):78-86. PubMed ID: 26152274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
    Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of micrometastases and its clinical significance in sentinel and non-sentinel lymph nodes from early cervical carcinoma].
    Lou HM; Zhu T; Shao F; Yang ZY; Fang XH; Feng JG
    Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):434-8. PubMed ID: 24119903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of programmed death-1 in sentinel lymph nodes of breast cancer.
    Tatara T; Mukohara T; Shimono Y; Yamasaki T; Imamura Y; Funakoshi Y; Toyoda M; Kiyota N; Takao S; Kono S; Kakeji Y; Minami H
    J Surg Oncol; 2018 May; 117(6):1131-1136. PubMed ID: 29193094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.